Literature DB >> 830776

Activation of complement components C3 and factor B in synovial fluids.

G G Hunder, F C McDuffie, B J Mullen.   

Abstract

Synovial fluids from 106 patients with various types of arthritis were examined for the presence of conversion products of C3 by means of crossed antigen-antibody electrophoresis and for products of factor B by immunoelectrophoresis. C3 conversion was found in all 15 fluids from patients with seropositive rheumatoid arthritis, in 11 of 15 with seronegative rheumatoid arthritis, in the majority with probable and possible rheumatoid arthritis, juvenile rheumatoid arthritis, SLE, pseudogout, gout, Reiter's syndrome, and frequently in other arthritides studied, but in only one of 15 with degenerative arthritis. In 53 synovial fluids a single C3 conversion peak was seen in addition to the native protein and in 18 others two conversion peaks were present. In many synovial fluids showing conversion whole-complement titers and C3 protein concentrations were normal. In both rheumatoid arthritis and crystal synovitis the per cent of C3 conversion, as estimated by planimetry, correlated with synovial fluid leukocyte counts, Factor B conversion was found in 31 fluids and usually occurred in fluids also showing C3 conversion. The findings indicate that in vivo activation of components of the classical and alternative considered mediated by immune complexes. Activation is also commonly present in a wide variety of other inflammatory arthritides and ofter would not be recognized by measuring only concentrations of hemolytic whole complement or C3 by immunodiffusion. The positive association between C3 conversion and synovial fluid polymorphonuclear leukocytes suggests that chemotactic factors generated from complement may be responsible for the attraction of leukocytes into the synovial space in these diseases.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 830776

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  9 in total

1.  Generation of superoxide by immunologically stimulated normal human neutrophils and possible modulation by intracellular and extracellular SOD and rheumatoid factors.

Authors:  M Shingu; T Todoroki; M Nobunaga
Journal:  Inflammation       Date:  1987-06       Impact factor: 4.092

2.  Superoxide generation by synovial fluid neutrophils enhanced by immune complexes and suppressed by rheumatoid factor in synovial fluid.

Authors:  T Todoroki; M Shingu; I Ezaki; M Nobunaga
Journal:  Rheumatol Int       Date:  1986       Impact factor: 2.631

Review 3.  Neutrophils, IL-1β, and gout: is there a link?

Authors:  Ioannis Mitroulis; Konstantinos Kambas; Konstantinos Ritis
Journal:  Semin Immunopathol       Date:  2013-01-24       Impact factor: 9.623

4.  Isolation and analysis of complement activating aggregates from synovial fluid of patients with rheumatoid arthritis using monoclonal anti-C3d antibodies.

Authors:  A E Bedwell; C J Elson; S D Carter; P A Dieppe; C W Hutton; R Czudek
Journal:  Ann Rheum Dis       Date:  1987-01       Impact factor: 19.103

5.  Protease inhibitors in rheumatoid synovial fluid. Analyses of electrophoretic homogeneity and protease inhibitory capacity.

Authors:  L Ekerot; K Ohlsson
Journal:  Rheumatol Int       Date:  1982       Impact factor: 2.631

6.  Relation between synovial fluid C3 degradation products and local joint inflammation in rheumatoid arthritis, osteoarthritis, and crystal associated arthropathy.

Authors:  M Doherty; N Richards; J Hornby; R Powell
Journal:  Ann Rheum Dis       Date:  1988-03       Impact factor: 19.103

7.  Relative contribution of contact and complement activation to inflammatory reactions in arthritic joints.

Authors:  J J Abbink; A M Kamp; J H Nuijens; A J Erenberg; A J Swaak; C E Hack
Journal:  Ann Rheum Dis       Date:  1992-10       Impact factor: 19.103

8.  Survey of synovial fluid cryoprecipitates.

Authors:  C L Ludivico; A R Myers
Journal:  Ann Rheum Dis       Date:  1980-06       Impact factor: 19.103

9.  Activation of the alternative pathway of complement by monosodium urate monohydrate crystals and other inflammatory particles.

Authors:  M Doherty; J T Whicher; P A Dieppe
Journal:  Ann Rheum Dis       Date:  1983-06       Impact factor: 19.103

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.